Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21230%2F14%3A00210910" target="_blank" >RIV/68407700:21230/14:00210910 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/60162694:G44__/14:43875024

Výsledek na webu

<a href="http://www.theglobaljournals.com/ijar/file.php?val=MzAxOA==" target="_blank" >http://www.theglobaljournals.com/ijar/file.php?val=MzAxOA==</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients

Popis výsledku v původním jazyce

Recently obesity has become a worldwide problém. It has become the most frequent metabolic disease as a result of life conditions and lifestyle changes which have resulted in a positive energetic balance The endpoint of the trial was a targeted reductionof excessive body weight in 99 individuals with BMI over 30 or 27 kg/m2 respectively. Three-month weight reduction therapy was based on the restriction of energy intake and pharmacotherapy by Sibutramine hydrochloride monohydrate (Sibutramine) 10 mg/person/day. Following the three-month therapy, weight loss, decrease of body fat, lower waist circumference, improved lipid profile and decreased of systolic as well as diastolic blood pressure were demonstrated. There was a statistically insignificant increase of heart rate during the study. Sibutramine therapy of obesity had no adverse effects that would result in the termination of therapy.

Název v anglickém jazyce

Effects of The Sibutramine Therapy on Selected Biochemical Parameters in Obese Patients

Popis výsledku anglicky

Recently obesity has become a worldwide problém. It has become the most frequent metabolic disease as a result of life conditions and lifestyle changes which have resulted in a positive energetic balance The endpoint of the trial was a targeted reductionof excessive body weight in 99 individuals with BMI over 30 or 27 kg/m2 respectively. Three-month weight reduction therapy was based on the restriction of energy intake and pharmacotherapy by Sibutramine hydrochloride monohydrate (Sibutramine) 10 mg/person/day. Following the three-month therapy, weight loss, decrease of body fat, lower waist circumference, improved lipid profile and decreased of systolic as well as diastolic blood pressure were demonstrated. There was a statistically insignificant increase of heart rate during the study. Sibutramine therapy of obesity had no adverse effects that would result in the termination of therapy.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

JC - Počítačový hardware a software

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Indian Journal of Applied Research

ISSN

2249-555X

e-ISSN

—

Svazek periodika

4

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

IN - Indická republika

Počet stran výsledku

4

Strana od-do

370-373

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—